Cite
NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia
MLA
Rolf Koehler, et al. “NOTCH1 Activation Clinically Antagonizes the Unfavorable Effect of PTEN Inactivation in BFM-Treated Children with Precursor T-Cell Acute Lymphoblastic Leukemia.” Haematologica, vol. 98, no. 6, Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e45df05ec23653d58deb15957e76194&authtype=sso&custid=ns315887.
APA
Rolf Koehler, Andreas E. Kulozik, Wolf-Dieter Ludwig, Martin Stanulla, Martin Schrappe, Martina U. Muckenthaler, Martin Zimmermann, Obul Reddy Bandapalli, & Corinne Kox. (2013). NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica, 98(6).
Chicago
Rolf Koehler, Andreas E. Kulozik, Wolf-Dieter Ludwig, Martin Stanulla, Martin Schrappe, Martina U. Muckenthaler, Martin Zimmermann, Obul Reddy Bandapalli, and Corinne Kox. 2013. “NOTCH1 Activation Clinically Antagonizes the Unfavorable Effect of PTEN Inactivation in BFM-Treated Children with Precursor T-Cell Acute Lymphoblastic Leukemia.” Haematologica 98 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0e45df05ec23653d58deb15957e76194&authtype=sso&custid=ns315887.